LEADER 01373nam  2200385Ia 450 
001 9910699265003321
005 20230902161934.0
035   $a(CKB)5470000002401255
035   $a(OCoLC)475002057
035   $a(EXLCZ)995470000002401255
100   $a20091207d2009      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aE 16 genomic biomarkers related to drug response$b[electronic resource] $econtext, structure, and format of qualification submissions
210  1$a[Rockville, Md.?] :$c[U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research],$d[2009]
215   $a1 online resource (9 pages)
300   $a"Draft"--title index p.
300   $a"7/30/2009"--title index p.
517   $aE 16 genomic biomarkers related to drug response 
606   $aGenomics$zUnited States
606   $aBiochemical markers$zUnited States
606   $aDrug approval$zUnited States
615  0$aGenomics
615  0$aBiochemical markers
615  0$aDrug approval
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699265003321
996   $aE 16 genomic biomarkers related to drug response$93494944
997   $aUNINA